The effects of the formula of amino acids enriched BCAA on nutritional support in traumatic patients

doi:10.3748/wjg.v9.i3.599

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3797)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

540

HTML

2870

Figures (1-2)

187

Tables (1-3)

200

Sum=3797

Mar 15, 2003 (publication date) through Dec 2, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Mar 15, 2003; 9(3): 599-602
Published online Mar 15, 2003. doi: 10.3748/wjg.v9.i3.599

Table 3 The changes of the amino acid pattern in serum after infusion

	Group	Case	Before infusion ^-x±s	After infusion ^-x±s	P value	Difference ^-x±s	P value
Asparagic acid(umol/L)	I	20	0.0748 ± 0.0672	0.0942 ± 0.0789	0.2580	0.0194 ± 0.0638	0.8728
	II	20	0.0633 ± 0.0413	0.0797 ± 0.0558	0.0999	0.0164 ± 0.0360
Threonine (umol/L)	I	20	0.1973 ± 0.1554	0.2829 ± 0.2147	0.0354	0.0856 ± 0.1424	0.2415
	II	20	0.1549 ± 0.0863	0.3154 ± 0.2331	0.0065	0.1601 ± 0.1943
Serine (umol/L)	I	20	0.2320 ± 0.1455	0.2600 ± 0.1701	0.4696	0.0279 ± 0.1456	0.5872
	II	20	0.1981 ± 0.1305	0.2518 ± 0.1576	0.0759	0.0537 ± 0.1086
Glutacid (umol/L)	I	20	0.2619 ± 0.2755	0.2829 ± 0.2146	0.8237	0.0209 ± 0.3574	0.3334
	II	20	0.2718 ± 0.2409	0.4212 ± 0.3217	0.1275	0.1493 ± 0.3570
Glycine (umol/L)	I	20	0.3844 ± 0.2695	0.5402 ± 0.3608	0.0173	0.1558 ± 0.2237	0.9325
	II	20	0.3722 ± 0.2207	0.5193 ± 0.3565	0.1028	0.1471 ± 0.3265
Alanine (umol/L)	I	20	0.5067 ± 0.3043	0.5737 ± 0.4167	0.5325	0.0669 ± 0.4053	0.1322
	II	20	0.4382 ± 0.2862	0.7291 ± 0.5371	0.0111	0.2908 ± 0.3849
Valine (umol/L)	I	20	0.2959 ± 0.2188	0.2722 ± 0.2168	0.6596	-0.0237 ± 0.2038	0.0264
	II	20	0.2601 ± 0.1494	0.4599 ± 0.3765	0.0249	0.1999 ± 0.3082
Cysteine (umol/L)	I	20	0.0138 ± 0.0180	0.0209 ± 0.0182	0.1043	0.0057 ± 0.0127	0.9373
	II	20	0.0300 ± 0.0202	0.0350 ± 0.0244	0.5238	0.0050 ± 0.0296
Methionine (umol/L)	I	20	0.0472 ± 0.0361	0.0590 ± 0.0498	0.3292	0.0118 ± 0.0452	0.4447
	II	20	0.0282 ± 0.0222	0.0516 ± 0.0440	0.0253	0.0234 ± 0.0362
Isoleucine (umol/L)	I	20	0.1030 ± 0.0728	0.1298 ± 0.0874	0.1973	0.0268 ± 0.0766	0.7457
	II	20	0.0825 ± 0.0586	0.1181 ± 0.0914	0.0730	0.0356 ± 0.0711
Leucine (umol/L)	I	20	0.2368 ± 0.1699	0.2496 ± 0.1694	0.7556	0.0128 ± 0.1557	0.3377
	II	20	0.1770 ± 0.1113	0.2399 ± 0.1674	0.0698	0.0629 ± 0.1242
Tyrosine (umol/L)	I	20	0.0774 ± 0.0511	0.0787 ± 0.0631	0.9380	0.0014 ± 0.0659	0.7263
	II	20	0.0584 ± 0.0378	0.0677 ± 0.0528	0.5343	0.0093 ± 0.0563
Phenylalanine (umol/L)	I	20	0.0897 ± 0.0960	0.1572 ± 0.1323	0.0289	0.0675 ± 0.1074	0.9835
	II	20	0.0736 ± 0.0518	0.1418 ± 0.1277	0.0138	0.0683 ± 0.0939
Lysine (umol/L)	I	20	0.1888 ± 0.1780	0.2311 ± 0.1984	0.3706	0.0422 ± 0.1767	0.6928
	II	20	0.1124 ± 0.1226	0.1836 ± 0.2403	0.2280	0.0712 ± 0.2187
Histidine (umol/L)	I	20	0.2517 ± 0.1691	0.2885 ± 0.2054	0.2654	0.0368 ± 0.1227	0.2958
	II	20	0.1907 ± 0.1041	0.2756 ± 0.1778	0.0196	0.0850 ± 0.1249
Arginine (umol/L)	I	20	0.1214 ± 0.2102	0.2534 ± 0.5048	0.1584	0.1320 ± 0.3433	0.0412
	II	20	0.2038 ± 0.4115	0.0480 ± 0.0678	0.1459	-0.1559 ± 0.3921
BCAA (umol/L)	I	20	0.6358 ± 0.4556	0.6516 ± 0.4014	0.8631	0.0158 ± 0.3494	0.0785
	II	20	0.5196 ± 0.3128	0.8180 ± 0.6279	0.0325	0.2984 ± 0.4869

I: AA group (the formula of amino acids); II: BCAA group (the formula of amino acids enriched BCAA).

Citation: Wang XY, Li N, Gu J, Li WQ, Li JS. The effects of the formula of amino acids enriched BCAA on nutritional support in traumatic patients. World J Gastroenterol 2003; 9(3): 599-602
URL: https://www.wjgnet.com/1007-9327/full/v9/i3/599.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i3.599